AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tateishi, U.
Right arrow Articles by Moriyama, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tateishi, U.
Right arrow Articles by Moriyama, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2003; 181:879-884
© American Roentgen Ray Society


CT and MRI Features of Recurrent Tumors and Second Primary Neoplasms in Pediatric Patients with Retinoblastoma

Ukihide Tateishi1, Tadashi Hasegawa2, Kunihisa Miyakawa1, Minako Sumi3 and Noriyuki Moriyama1

1 Division of Diagnostic Radiology, National Cancer Center Hospital and Research Institute, 5-1-1, Tsukiji, Chuo-Ku, 104-0045 Tokyo, Japan.
2 Division of Pathology, National Cancer Center Hospital and Research Institute, Chuo-Ku, 104-0045 Tokyo, Japan.
3 Division of Radiation Oncology, National Cancer Center Hospital and Research Institute, Chuo-Ku, 104-0045 Tokyo, Japan.

Received January 24, 2003; accepted after revision March 27, 2003.

 
Address correspondence to U. Tateishi.


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. The aim of our study was to describe the CT and MRI findings of recurrent tumors and second primary (malignant and benign) neoplasms in patients with retinoblastoma and to evaluate imaging features to assist in distinguishing them.

MATERIALS AND METHODS. Records of 445 pathologically confirmed retinoblastomas were retrospectively reviewed. Thirty-four patients with recurrent retinoblastomas and 15 patients with second primary neoplasms who underwent CT and MRI were evaluated by two radiologists with agreement by consensus.

RESULTS. Invasive patterns of recurrent tumors included type A, intraocular tumor (n = 13); type B, intraorbital tumor with spread into the optic nerve shown as enlargement and marked enhancement of the optic nerve on contrast-enhanced CT or MRI (n = 6); and type C, tumor extending to the lateral aspect of the orbit and invading the brain via the sphenoidal bone (n = 2). Thirty-eight percent of patients with recurrent tumors had distant metastases (n = 7) or leptomeningeal metastases (n = 6). Leptomeningeal metastases were found only in recurrent tumors. Second primary neoplasms included osteosarcoma (n = 5), rhabdomyosarcoma (n = 5), meningioma (n = 4), and other tumors (n = 3). A significant difference was seen between the patients' ages at the time of diagnosis of recurrent tumors and second primary neoplasms (p < 0.0001). Extraorbital tumors were found more frequently among second primary neoplasms than among recurrent tumors (p < 0.001).

CONCLUSION. Both recurrent tumors and second primary neoplasms in patients with retinoblastoma often show characteristic imaging features. The tumor distribution on CT and MRI may help in differentiating recurrent tumors and second primary neoplasms.


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Retinoblastoma is the most common primary ocular malignancy of early childhood. The tumor is hereditary in all patients with bilateral retinoblastoma and in 10-15% of those with unilateral disease identified by a family history of retinoblastoma [1, 2]. Although the cure rate of retinoblastoma is excellent after enucleation or irradiation, survivors of hereditary retinoblastoma are at increased risk of developing recurrent tumors or second primary (malignant and benign) neoplasms, most commonly osteosarcoma and other soft-tissue sarcomas [1-10]. Loss or mutation of the retinoblastoma gene, which is a prototypical tumor-suppressor gene located on human chromosome 13q14, has been associated with development of other malignancies, including osteosarcoma and other mesenchymal tumors [11-13].

The incidence of second primary neoplasms after retinoblastoma increases with the length of time from initial diagnosis, with a cumulative incidence of 8.4% 18 years after diagnosis [10]. However, a short latency has been found among patients with recurrent tumors, and the incidence may be overestimated because of difficulties in distinguishing second primary neoplasms from recurrent tumors. Second primary neoplasms often show both high-grade and undifferentiated features on microscopic observation, making them difficult to diagnose and distinguish from the small, undifferentiated round cell tumors that are characteristic of recurrent retinoblastomas [14-21]. Although the CT and MRI findings of patients with retinoblastoma are established, there have been only a few descriptions of second primary neoplasms in patients with retinoblastoma [22]. In our study, we retrospectively reviewed and described CT and MRI findings in recurrent tumors and second primary neoplasms in patients with retinoblastoma.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
We reviewed cross-referenced records from January 1980 to September 2002 in the divisions of radiation oncology and pathology at the National Cancer Center Hospital, Tokyo, and identified 445 patients with pathologically confirmed retinoblastoma. Of these, 34 patients with recurrent retinoblastomas and 15 patients with second primary neoplasms were included in our study. Of the 15 patients with second primary neoplasms, two patients developed two separate second primary tumors. One child had a temporal rhabdomyosarcoma and developed osteosarcoma 12 years later. Another child first developed meibomian carcinoma in the eyelid, followed 5 years later by a meningioma arising in the skull base. Therefore, we reviewed 15 patients with 17 second primary neoplasms for data analysis. Patients seen in consultation were included in the analysis even if they did not receive all primary therapy for retinoblastoma at our institute because some children were referred with recurrent disease after having initial treatment at an outside institution.

Of the 49 patients evaluated, data regarding age at diagnosis; sex; family history; histologic subtype; location; latent period; and all initial treatment for primary tumors including enucleation, chemotherapy, radiation therapy, and treatment of recurrent tumors and second primary neoplasms were documented. Patients with recurrent tumors or second primary neoplasms received combined modality therapy consisting of surgical resection or biopsy, followed by combination chemotherapy either in standard doses or in escalating doses with autologous bone marrow or peripheral blood stem cell transplantation, with or without radiation therapy. The latent period was calculated from the time of initial diagnosis to the time of diagnosis of recurrent tumors or second primary neoplasms. All tumors in the field of radiation were so classified if they appeared to be originating in the eyelids, orbits, paranasal sinuses, temporal bones, or soft tissues overlying the temporal bone region.

CT and MRI examinations were reviewed by two radiologists with agreement by consensus. The images of 49 patients included both CT and MRI (n = 27), only CT (n = 3), or only MRI (n = 19). Unenhanced CT scans were obtained in 30 patients, and contrast-enhanced CT scans were obtained in 24 patients with the use of IV iodinated contrast material. Section thickness ranged between 5 and 10 mm. CT scans were evaluated for predominant attenuation; homogeneity or heterogeneity; and the presence of calcification, bone destruction, surrounding edema, and tumor enhancement.

MRI was performed using 1.5-T systems. Using the spin-echo technique, we obtained T1-weighted images (TR range/TE range, 400-660/12-15) in the axial and coronal planes. T2-weighted spin-echo or fast spin-echo images (3000-5700/80-118) were then obtained in the axial and coronal planes. Whole-brain images were obtained with a field of view of 30-40 cm, an image matrix of 128 x 256, and a slice thickness of 5-10 mm. Locations were judged by the type of margin, extent of tissue involvement, internal architecture, presence of invasion to surrounding tissue, size, and signal characteristics on T1- and T2- weighted images. Tumor size was determined by the largest diameter in the axial plane of CT scans or MRIs. Locations were correlated with the radiation field in all patients. Signal characteristics were described as hypointense, isointense, or hyperintense relative to the surrounding structures: muscle or white matter. MRIs obtained after the IV administration of a gadolinium chelate with T1-weighting (n = 30) were evaluated for the degree and type of enhancement.

For evaluation of recurrent tumors in patients with retinoblastoma, we categorized growth patterns into three types for assessing recurrent retinoblastoma: intraocular tumor (type A), intraorbital tumor with local spread into the optic nerve (type B), and tumor extending to the lateral aspect of the orbit and invading the brain via the sphenoidal bone (type C).

CT and MRI findings were assessed in both recurrent tumors and each histologic type of second primary neoplasms. We also assessed CT and MRI findings to assist in the differentiation of recurrent tumors and second primary neoplasms.

The data obtained related to disease status regarding retinoblastoma and the second primary neoplasms in all patients. Current status was documented by follow-up examination, and follow-up was calculated in months from the date of initial diagnosis to the most recent follow-up. Differences between subgroups were analyzed for correlations with the chi-square test, Fisher's exact probability test, or Spearman's rank correlation coefficient test. The interobserver variation of the extent of various abnormalities was evaluated with the Spearman's rank correlation coefficient test. A p value of less than 0.05 was considered a statistically significant difference.


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Clinical Findings
The clinical features of the patients are summarized in Table 1. A significant difference was seen in age at the time of diagnosis between patients with recurrent tumors and those with second primary neoplasms (p < 0.0001). Patients with hereditary tumors developed second primary neoplasms more frequently than they developed recurrent tumors (p < 0.001). The initial therapy for patients with both tumor types included combination therapy. No significant difference was found in the radiation dose between recurrent tumors and second primary neoplasms. The latent period of second primary tumors ranged between 15 and 400 months (median ± SD, 178.7 ± 28.7 months). There was a significant difference in the latent period between recurrent tumors and second primary neoplasms (p < 0.0001). The significant difference was also found in the latent period between histologic subtypes including osteosarcoma, rhabdomyosarcoma, and meningioma (Table 2). Seventy-one percent of patients with recurrent tumors and 73% of patients with second primary neoplasms were still alive, with a median follow-up of 58.2 and 271.3 months, respectively.


View this table:
[in this window]
[in a new window]

 
TABLE 1 Characteristics of Patients with Retinoblastoma

 

View this table:
[in this window]
[in a new window]

 
TABLE 2 Second Primary Neoplasms in Patients with Retinoblastoma

 

Imaging Features in Recurrent Tumors
Sixty-two percent of patients with recurrent tumors had local lesions. Invasive patterns (Fig. 1) of recurrent tumors identified on CT or MRI included type A, intraocular tumor (n = 13, 38%) (Fig. 2); type B, intraorbital tumor with spread into the optic nerve shown as enlargement and marked enhancement of the optic nerve on contrast-enhanced CT or MRI (n = 6, 18%) (Fig. 3); and type C, tumor extending to the lateral aspect of the orbit and invading the brain via the sphenoidal bone (n = 2, 6%) (Fig. 4). Peripherally located intralesional calcification was found in type A (n = 13, 100%) and type B (n = 2, 33%) tumors on unenhanced CT. In addition, no calcification was found in type C tumors. Tumors appeared hypo- to isointense in relation to normal temporal muscle on T1-weighted images and of moderately high signal intensity on T2-weighted images in all patients who underwent MRI. All localized lesions were depicted as heterogeneously enhanced masses with a slightly irregular surface on contrast-enhanced CT or MRI.



View larger version (22K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1. Drawing shows types of tumor extension in recurrent retinoblastoma. Three growth patterns are present in recurrent retinoblastoma: intraocular tumor (type A), intraorbital tumor with local spread into optic nerve (type B), and tumor extending to lateral aspect of orbit and invading brain via sphenoidal bone (type C).

 


View larger version (145K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2. 2-year-old boy with recurrent retinoblastoma who underwent enucleation of left eye and irradiation of both eyes. Axial T2-weighted image (TR/TE, 4000/118) shows soft-tissue mass in right globe (type A). Tumor (arrowheads) shows heterogeneous high signal intensity relative to temporal muscle.

 


View larger version (139K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3. 3-year-old boy with recurrent retinoblastoma who underwent irradiation of left eye. Axial contrast-enhanced T1-weighted image (TR/TE, 630/15) shows recurrent tumor (arrowheads) that extended into optic nerve (type B) with heterogeneous enhancement.

 


View larger version (149K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4. 6-year-old boy with recurrent retinoblastoma who underwent enucleation and irradiation of left eye. Axial contrast-enhanced T1-weighted image (TR/TE, 600/15) shows tumor extension (arrows) through greater wing of sphenoid to middle cranial fossa (type C).

 

Thirty-eight percent of patients with recurrent tumors had distant metastases (n = 7) or leptomeningeal metastases (n = 6) (Fig. 5). Multiple brain metastases were found in three patients. Although the signal characteristics on T1- and T2-weighted images were nonspecific, lesions showed heterogeneous enhancement on contrast-enhanced CT or MRI. One patient developed skull metastasis that was seen as focal bone destruction on unenhanced CT and a moderately enhanced mass on contrast-enhanced MRI.



View larger version (148K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5. 4-year-old boy with recurrent retinoblastoma who underwent enucleation, irradiation, and chemotherapy. Coronal contrast-enhanced T1-weighted image (TR/TE, 400/15) shows multiple leptomeningeal metastases (arrowheads).

 

Imaging Features in Second Primary Neoplasms
Seventeen second primary neoplasms included various histologic types of tumors. Malignant tumors consisted of osteosarcoma (n = 5), rhabdomyosarcoma (n = 5), malignant fibrous histiocytoma (n = 1), and meibomian gland carcinoma (n = 1), whereas benign tumors were meningioma (n = 4) (Table 2).

Osteosarcoma was one of the frequent histologic subtypes (29%). Tumors originated from previously irradiated regions, including the intraorbit (n = 2), temporal bone (n = 1), and ethmoid bone (n = 1). One patient developed a tumor in the distal femur outside the irradiated field. Unenhanced CT scans revealed irregular masses in the orbit, temporal bone, or ethmoid bone with calcification (n = 4, 80%) (Fig. 6). Two tumors showed severe bone destruction on unenhanced CT. Contrast-enhanced CT and MRI showed heterogenous enhancement with perifocal edema (n = 5, 100%). Fluid-fluid levels, suggestive of hemorrhage, were identified in two tumors on T2-weighted images. Calcification identified on unenhanced CT corresponded in part to areas of signal voids or low signal intensity on both T1- and T2-weighted images.



View larger version (151K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6. Osteosarcoma in 25-year-old man with hereditary retinoblastoma who underwent enucleation, irradiation, and chemotherapy of both eyes. Axial CT scan shows faintly calcified mass (arrowheads) of temporal bone invading both brain and soft tissues.

 

All rhabdomyosarcomas arose in the region previously irradiated, including five tumors that developed in the temporal muscle within the irradiated field and one that involved the contralateral temporal muscle, which may have received a radiation dose of 50-60% of that in the irradiated field. Unenhanced CT revealed well-defined masses with ovoid contours situated in the temporal muscle (n = 5, 100%). Five patients underwent both contrast-enhanced CT and MRI; of these, three tumors (60%) showed heterogeneous and slight enhancement relative to the adjacent muscle (Fig. 7). Fluid-fluid levels were found in one tumor on both T1- and T2-weighted images. Signal characteristics on T1- and T2-weighted images were nonspecific in the other four tumors.



View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7. Rhabdomyosarcoma in 5-year-old girl with retinoblastoma who underwent irradiation in right eye. Axial T2-weighted image (TR/TE, 5700/105) shows well-defined soft-tissue mass arising from deep aspect of temporal muscle. Tumor (arrowheads) shows high signal intensity relative to muscle.

 

A 16-year-old girl with hereditary retinoblastoma developed malignant fibrous histiocytoma in the orbit, with severe destruction of bone identified on unenhanced CT (Fig. 8). The tumor showed nonspecific signal characteristics on T1- and T2-weighted images, but marked enhancement was found on contrast-enhanced CT scans and MRIs. A 20-year-old woman developed a well-defined mass in the eyelid that was seen on unenhanced CT and diagnosed as a meibomian gland carcinoma after a latent period of 121 months. The tumor showed nonspecific signal characteristics on both T1- and T2-weighted images, but areas of marked enhancement were found on contrast-enhanced MRIs (Figs. 9A, and 9B).



View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 8. Malignant fibrous histiocytoma in 16-year-old girl with hereditary retinoblastoma who underwent enucleation and irradiation in right eye. Axial contrast-enhanced CT scan shows irregular mass (arrow) with bone destruction in orbit.

 


View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 9A. Meibomian gland carcinoma in 20-year-old woman with hereditary retinoblastoma who underwent enucleation and irradiation. Axial T1-weighted image (TR/TE, 600/15) shows well-defined soft-tissue mass (arrow) in orbit.

 


View larger version (126K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 9B. Meibomian gland carcinoma in 20-year-old woman with hereditary retinoblastoma who underwent enucleation and irradiation. Axial contrast-enhanced T1-weighted image (600/15) shows marked enhancement of tumor.

 

All meningiomas originated from the previously irradiated skull base. Tumors showed hyperattenuation on unenhanced CT (n = 4), and marked enhancement was found in all cases on contrast-enhanced CT and MRI (Fig. 10). Punctate calcification was found in one case; this tumor was associated with secondary hyperplastic change of the adjacent bone. Signal characteristics were nonspecific on T1- and T2-weighted images. However, perifocal edema was found in three cases in the adjacent white matter on T2-weighted images.



View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 10. Meningioma in 24-year-old man with hereditary retinoblastoma who underwent enucleation and irradiation. Axial contrast-enhanced T1-weighted image (TR/TE, 600/15) shows extraaxial mass with marked enhancement adjacent to sphenoid bone.

 

Differentiation Between Recurrent Tumors and Second Primary Neoplasms
Peripherally located intralesional calcification was found in all type A and in 33% of type B tumors on unenhanced CT. However, this finding was similar to that of osteosarcoma arising in the orbit. Three invasive patterns of recurrent tumors were identified on CT or MRI, whereas only two patients with second primary tumors showed these patterns. However, this configuration of invasive patterns did not assist in the differentiation of recurrent tumors and second primary neoplasms (Table 3). Brain metastases and leptomeningeal metastases were found only in recurrent tumors. A statistically significant difference was found in intra- and extraorbital location of tumors between recurrent tumors and second primary neoplasms (Table 4).


View this table:
[in this window]
[in a new window]

 
TABLE 3 Invasive Patterns in Recurrent Tumors and Second Primary Neoplasms

 

View this table:
[in this window]
[in a new window]

 
TABLE 4 Intra- and Extraorbital Tumor Location

 


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
In our study, we described the CT and MRI findings of both recurrent tumors and second primary neoplasms in patients with retinoblastoma. The short latency among patients with retinoblastoma is one factor that encourages us to question whether their new lesions are recurrent tumors or second primary neoplasms. Second primary neoplasms tend to appear after longer intervals, usually showing a latent period of at least 10 years [1, 2]. This finding was mostly in accordance with our results. However, two cases of second primary neoplasms had much shorter latent periods of 15 months. Our results show that both the recurrent tumors and the second primary neoplasms may be seen in the same latent periods. The type of second primary neoplasm appears to be related to the latent period. Rhabdomyosarcoma seems to occur earlier than other tumors, with a relatively short latency ranging from 15 to 93 months. Osteosarcoma is usually considered to be the most frequent second primary tumor in patients with hereditary retinoblastoma. The relatively short follow-up periods in earlier studies probably gave the misleading impression that it is osteosarcoma that preferentially develops in patients who have survived a hereditary tumor at an earlier age than other types of second primary neoplasms.

CT and MRI can show tumor extension by three types of growth patterns in primary retinoblastoma: the endophytic type, in which the tumor projects anteriorly and grows into the vitreous; the exophytic type, in which the tumor arises intraretinally and subsequently grows into the subretinal space; and the diffuse infiltrating type, in which tumor growth in the retina appears as a plaquelike mass [14-16]. Our results also suggested that three growth patterns might exist in recurrent retinoblastoma, and that CT and MRI can detect tumor extension: intraocular tumor (type A), intraorbital tumor with local spread into the optic nerve (type B), and tumor extending to the lateral aspect of the orbit and invading the brain via the sphenoidal bone (type C).

Different types of second primary neoplasms have also been documented in previous studies, with most of the second primary neoplasms being soft-tissue sarcomas, followed by melanomas, brain tumors, leukemias, and other epithelial tumors [1-9]. In our study, the most common types of second primary neoplasms in patients with retinoblastoma were osteosarcoma and rhabdomyosarcoma.

Osteosarcoma is one of the most frequent second primary neoplasms originating from a previously irradiated region. Calcification within the tumor that depends on the amount of mineralization is observed on CT. Four of our patients showed central calcification within the mass on unenhanced CT. An important feature to diagnose osteosarcoma on CT may be central calcification within the mass situated in the irradiated field, including the intraorbit, temporal bone, and ethmoid bone. Extraskeletal osteosarcoma presents nonspecific signal characteristics on MRI: a mass with mixed low signal intensity on T1-weighted images and mixed but predominantly high signal intensity on T2-weighted images [23-25]. Fluid-fluid levels, suggestive of hemorrhage, were identified in two of our patients on T2-weighted images; this finding was consistent with a previous report [23].

Rhabdomyosarcoma also presents with rather nonspecific CT and MRI findings, but some characteristic findings were discovered in our patients. All rhabdomyosarcomas arose within the region previously irradiated. As a rule, rhabdomyosarcomas in the head and neck region grow rapidly, often in an infiltrative and destructive manner [26, 27]. However, all of our patients presented with well-defined masses with ovoid contours situated in the temporal muscle on both CT and MRI. The MRI signal characteristics and enhancement patterns identified on both contrast-enhanced CT and MRI were nonspecific. Few characteristic imaging findings reflect the degree of cellularity; the relative amounts of collagen; and the presence and extent of secondary changes such as hemorrhage, necrosis, and ulceration.

The initial therapy for primary tumors has been enucleation of the most severely affected eye and irradiation of the contralateral eye to preserve vision. Patients with hereditary retinoblastoma may have an increased susceptibility to the induction of second primary neoplasms by radiation [28].

Radiation increases the total risk in addition to the already high incidence because more second primary tumors develop in the irradiated field than outside the irradiated field [2]. Sarcomas can be categorized as radiation-induced if they meet the following criteria: tumor must develop within the boundaries of a previously irradiated area, a relatively long asymptomatic latent period (>= 4 years) must have elapsed, the tumor must have a different histology from the original lesion, and the tumor must be histologically confirmed [28]. Most of our cases of second primary neoplasms arose in the irradiated field. However, some tumors occurred with relatively short latency and outside the irradiation field. Similar findings have suggested that nearly all second primary neoplasms occur among hereditary retinoblastoma tumors, and that many second primary tumors occur outside the irradiation field, with some among nonirradiated tumors [2, 28]. Second primary neoplasms in patients with retinoblastoma may occur both as a result of, and independently of, radiation therapy. However, the follow-up period and the number of patients with second primary neoplasms in our study are not sufficient for conclusive analysis. Further follow-up study is necessary to evaluate the relationship between irradiation and the occurrence of second primary neoplasms in patients with retinoblastoma.

In conclusion, several kinds of imaging features were present both in recurrent tumors and in second primary neoplasms in patients with retinoblastoma. The tumor distribution on CT and MRI may help in differentiating recurrent tumors and second primary neoplasms.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Smith LM, Donaldson SS, Egbert PR, Link MP, Bagshaw MA. Aggressive management of secondary primary tumors in survivors of hereditary retinoblastoma. Int J Radiat Oncol Biol Phys1989; 17:499 -505[Medline]
  2. Abramson DH, Ellsworth RM, Kitchin FD, Tung G. Second nonocular tumors in retinoblastoma survivors: are they radiation-induced? Ophthal mology1984; 91:1351 -1355
  3. Derkinderen DJ, Koten JW, Nagelkerke NJD, Tan KE, Beemer FA, Den Otter W. Non-ocular cancer in patients with hereditary retinoblastoma and their relatives. Int J Cancer1988; 41:499 -504[Medline]
  4. Dickman PS, Barmada M, Gollin SM, Blatt J. Malignancy after retinoblastoma: secondary cancer or recurrence? Hum Pathol 1997;28:200 -205[Medline]
  5. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblas toma. Br J Cancer1986; 53:661 -671[Medline]
  6. Dunkel IJ, Gerald WL, Rosenfield NS, Strong EW, Abramson DH, Ghavimi F. Outcome of patients with a history of bilateral retinoblastoma treated for second malignancy: the Memorial Sloan-Kettering experience. Med Pediatr Oncol1998; 30:59 -62[Medline]
  7. Chemello PD, Nelson CL, Tomich CE, Sadove AM. Embryonal rhabdomyosarcoma arising in the masseter muscle as a second malignant neoplasm. J Oral Maxillofac Surg1988; 46:899 -905[Medline]
  8. Hasegawa T, Matsuno Y, Niki T, et al. Second primary rhabdomyosarcomas in patients with bilateral retinoblastoma: a clinicopathologic and immunohistochemical study. Am J Surg Pathol 1998;22:1351 -1360[Medline]
  9. Walford N, Deferrai R, Slater RM, et al. Intraorbital rhabdoid tumour following bilateral retinoblastoma. Histopathology1992; 20:170 -173[Medline]
  10. Moll AC, Imhof SM, Bouter LM, Tan KE. Second primary tumors in patients with retinoblastoma: a review of the literature. Ophthalmic Genet1997; 18:27 -34[Medline]
  11. Scholz RB, Kabisch H, Delling G, Winkler K. Homozygous deletion within the retinoblastoma gene in a native osteosarcoma specimen of a patient cured of a retinoblastoma of both eyes. Pediatr Hematol Oncol 1990;7:265 -273[Medline]
  12. Issing WJ, Wustrow TP, Oeckler R, Mezger J, Nerlich A. An association of the RB gene with osteosarcoma: molecular genetic evaluation of a case of hereditary retinoblastoma. Eur Arch Otorhinolaryngol 1993;250:277 -280[Medline]
  13. Rieder H, Lohmann D, Poensgen B, et al. Loss of heterozygosity of the retinoblasoma (RB1) gene in lipomas from a retinoblastoma patient. J Natl Cancer Inst1998; 90:324 -326[Free Full Text]
  14. Mafee MF, Goldberg MF, Greenwald MJ, Schulman J, Malmed A, Flanders AE. Retinoblastoma and simulating lesions: role of CT and MR imaging. Radiol Clin North Am1987; 25:667 -682
  15. Danziger A, Prince HI. CT findings in retinoblas toma. AJR 1979;133:695 -697[Abstract]
  16. Kaufman LM, Mafee MF, Song CD. Retinoblas toma and simulating lesions: role of CT, MR imag ing, and use of Gd-DTPA contrast enhancement. Radiol Clin North Am1998; 36:1101 -1117[Medline]
  17. Brisse HJ, Lumbroso L, Freneaux PC, et al. Sonographic, CT, and MR imaging findings in diffuse infiltrative retinoblastoma: report of two cases with histologic comparison. AJNR2001; 22:499 -504[Abstract/Free Full Text]
  18. Beets-Tan RG, Hendriks MJ, Ramos LM, Tan KE. Retinoblastoma: CT and MRI. Neuroradiology1994; 36:59 -62[Medline]
  19. O'Brien JM. Retinoblastoma: clinical presentation and the role of neuroimaging. AJNR2001; 22:426 -428
  20. Char DH, Hedges TR, Norman D. Retinoblastoma: CT diagnosis. Ophthalmology1984; 91:1347 -1350[Medline]
  21. Arrigg PG, Hedges TR, Char DH. Computed tomography in the diagnosis of retinoblastoma. Br J Ophthalmol1983; 67:588 -591[Abstract/Free Full Text]
  22. Chan LL, Czerniak BA, Ginsberg LE. Radiation-induced osteosarcoma after bilateral childhood retinoblastoma. AJR2000; 174:1288[Free Full Text]
  23. Murphey MD, Robbin MR, McRae GA, Flemming DJ, Temple HT, Kransdorf MJ. The many faces of os teosarcoma. RadioGraphics1997; 17:1205 -1231[Abstract]
  24. Moser RP Jr. Musculoskeletal case of the day: ex traskeletal osteosarcoma of the thigh. AJR1994; 162:1463 -1465[Free Full Text]
  25. Varma DG, Ayala AG, Guo SQ, Moulopoulos LA, Kim EE, Charnsangavej C. MRI of extraskeletal osteosarcoma. J Comput Assist Tomogr 1993;17:414 -417[Medline]
  26. Lee JH, Lee MS, Lee BH, et al. Rhabdomyosarcoma of the head and neck in adults: MR and CT findings. AJNR1996; 17:1923 -1928[Abstract]
  27. Yang WT, Kwan WH, Li CK, Metreweli C. Imag ing of pediatric head and neck rhabdomyosarco mas with emphasis on magnetic resonance imaging and a review of the literature. Pediatr Hematol Oncol1997; 14:243 -257[Medline]
  28. Schwarz MB, Burgess LP, Fee WE, Donaldson SS. Postirradiation sarcoma in retinoblastoma: induction or predisposition? Arch Otolaryngol Head Neck Surg1988; 114:640 -644[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
S. M. Sabourin, A. Jayashankar, and M. E. Mullins
Imaging of Osteosarcoma After Irradiation: Self-Assessment Module
Am. J. Roentgenol., September 1, 2008; 191(3_Supplement): S28 - S30.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. M. Sabourin, A. Jayashankar, and M. E. Mullins
AJR Teaching File: Lump on the Head
Am. J. Roentgenol., September 1, 2008; 191(3_Supplement): S31 - S33.
[Full Text] [PDF]


Home page
RadioGraphicsHome page
E. M. Chung, M. D. Murphey, C. S. Specht, R. Cube, and J. Smirniotopoulos
From the Archives of the AFIP * Pediatric Orbit Tumors and Tumorlike Lesions: Osseous Lesions of the Orbit
RadioGraphics, July 1, 2008; 28(4): 1193 - 1214.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tateishi, U.
Right arrow Articles by Moriyama, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tateishi, U.
Right arrow Articles by Moriyama, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS